首页|期刊导航|老年心脏病学杂志(英文版)|Clinical value of detecting autoantibodies against β1-, β2-, and α1-adrenergic receptors in carvedilol treatment of patients with heart failure
老年心脏病学杂志(英文版)2020,Vol.17Issue(6):305-312,8.DOI:10.11909/j.issn.1671-5411.2020.06.002
Clinical value of detecting autoantibodies against β1-, β2-, and α1-adrenergic receptors in carvedilol treatment of patients with heart failure
Clinical value of detecting autoantibodies against β1-, β2-, and α1-adrenergic receptors in carvedilol treatment of patients with heart failure
摘要
关键词
Adrenergic receptors/Autoantibodies/Cardiac function/Carvedilol/Heart failureKey words
Adrenergic receptors/Autoantibodies/Cardiac function/Carvedilol/Heart failure引用本文复制引用
Dong-Yan HOU,Lin ZHANG,Lin XU,Zhi-Yong ZHANG,Xiao-Rong XU,Xin WANG,Juan ZHANG,Jia-Mei LIU,Hua WANG,Jin CHEN..Clinical value of detecting autoantibodies against β1-, β2-, and α1-adrenergic receptors in carvedilol treatment of patients with heart failure[J].老年心脏病学杂志(英文版),2020,17(6):305-312,8.基金项目
This study was supported by the Beijing Natural Science Foundation (No.7174306).We would like to extend our heartfelt thanks to the patients and their families whose participation made this project possible.All authors had no conflicts of interest to disclose. (No.7174306)